Atlas Trials

Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma

Clinical trial NCT01242930 · COMPLETED

Trial details

NCT number
NCT01242930
Sponsor
Geron Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2010-11-01
Primary completion
2014-11-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.